Beam Therapeutics Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Millions MXN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	46,266	41,131	36,504	52,503	109,210	91,742
Market Cap Growth	10.67%	12.67%	-30.47%	-51.92%	19.04%	-
Enterprise Value	30,396	25,217	22,278	34,634	93,056	88,401
Last Close Price	604.00	531.00	750.00	-	-	-
PS Ratio	45.28	31.08	5.72	44.18	102.75	192105.00
PB Ratio	2.61	2.69	2.20	3.67	6.44	18.77
P/TBV Ratio	2.61	2.69	2.20	3.67	6.44	18.77
P/OCF Ratio	-	-	-	119.48	-	-
EV/Sales Ratio	31.76	19.05	3.49	29.15	87.56	185109.63
Debt / Equity Ratio	0.16	0.22	0.18	0.25	0.18	0.44
Asset Turnover	0.05	0.05	0.27	0.04	0.05	0
Quick Ratio	5.89	4.67	5.79	4.82	5.93	2.93
Current Ratio	6.02	4.82	5.89	4.89	5.96	3.01
Return on Equity (ROE)	-47.19%	-43.94%	-15.46%	-37.06%	-69.13%	-112.32%
Return on Assets (ROA)	-23.48%	-20.26%	-7.88%	-15.02%	-15.41%	-27.30%
Return on Capital Employed (ROCE)	-41.30%	-45.10%	-14.10%	-30.30%	-18.80%	-38.00%
Earnings Yield	-16.44%	-19.09%	-6.14%	-10.74%	-6.96%	-4.22%
FCF Yield	-13.97%	-18.05%	-8.47%	-0.98%	-2.12%	-2.43%
Buyback Yield / Dilution	-14.73%	-6.69%	-10.19%	-9.01%	-37.44%	-621.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.